Mederos, M. A., Reber, H. A. & Girgis, M. D. Acute pancreatitis: a evaluate. JAMA 325, 382–390 (2021).
Jaber, S. et al. Tips for the administration of sufferers with extreme acute pancreatitis, 2021. Anaesth. Crit. Care Ache. Med 41, 101060 (2022).
Banks, P. A. et al. Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by worldwide consensus. Intestine 62, 102–111 (2013).
Mareninova, O. A. et al. Cell dying in pancreatitis: caspases shield from necrotizing pancreatitis. J. Biol. Chem. 281, 3370–3381 (2006).
Louhimo, J., Steer, M. L. & Perides, G. Necroptosis is a vital severity determinant and potential therapeutic goal in experimental extreme pancreatitis. Cell Mol. Gastroenterol. Hepatol. 2, 519–535 (2016).
Cao, Y., Adhikari, S., Clément, M. V., Wallig, M. & Bhatia, M. Induction of apoptosis by crambene protects mice in opposition to acute pancreatitis through anti-inflammatory pathways. Am. J. Pathol. 170, 1521–1534 (2007).
Zhu, Q. et al. The TRIM28/miR133a/CD47 axis acts as a possible therapeutic goal in pancreatic necrosis by impairing efferocytosis. Mol. Ther. 32, 3025–3041 (2024).
Tashiro, M., Schäfer, C., Yao, H., Ernst, S. A. & Williams, J. A. Arginine induced acute pancreatitis alters the actin cytoskeleton and will increase warmth shock protein expression in rat pancreatic acinar cells. Intestine 49, 241–250 (2001).
Hoque, R., Malik, A. F., Gorelick, F. & Mehal, W. Z. Sterile inflammatory response in acute pancreatitis. Pancreas 41, 353–357 (2012).
Zhao, Q., Wei, Y., Pandol, S. J., Li, L. & Habtezion, A. STING signaling promotes irritation in experimental acute pancreatitis. Gastroenterology 154, 1822–1835.e2 (2018).
Sendler, M. et al. NLRP3 inflammasome regulates growth of systemic inflammatory response and compensatory anti-inflammatory response syndromes in mice with acute pancreatitis. Gastroenterology 158, 253–269.e14 (2020).
Nagata, S. Apoptosis and clearance of apoptotic cells. Annu Rev. Immunol. 36, 489–517 (2018).
Arandjelovic, S. & Ravichandran, Okay. S. Phagocytosis of apoptotic cells in homeostasis. Nat. Immunol. 16, 907–917 (2015).
Vago, J. P. et al. Proresolving actions of artificial and pure protease inhibitors are mediated by annexin A1. J. Immunol. 196, 1922–1932 (2016).
Shen, X., Zhang, S., Guo, Z., Xing, D. & Chen, W. The crosstalk of ABCA1 and ANXA1: a possible mechanism for cover in opposition to atherosclerosis. Mol. Med 26, 84 (2020).
McArthur, S. et al. Annexin A1: a central participant within the anti-inflammatory and neuroprotective position of microglia. J. Immunol. 185, 6317–6328 (2010).
Tzelepis, F. et al. Annexin1 regulates DC efferocytosis and cross-presentation throughout Mycobacterium tuberculosis an infection. J. Clin. Make investments. 125, 752–768 (2015).
da Rocha, G. H. O. et al. Management of expression and exercise of peroxisome proliferated-activated receptor γ by annexin A1 on microglia throughout efferocytosis. Cell Biochem. Funct. 37, 560–568 (2019).
Solar, L., Wu, J., Du, F., Chen, X. & Chen, Z. J. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that prompts the sort I interferon pathway. Science 339, 786–791 (2013).
Gao, D. et al. Cyclic GMP-AMP synthase is an innate immune sensor of HIV and different retroviruses. Science 341, 903–906 (2013).
Wu, J. et al. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 339, 826–830 (2013).
Wang, Z. et al. Growth and purposes of mRNA remedy primarily based on lipid nanoparticles. Biotechnol. Adv. 65, 108130 (2023).
Patel, S. Okay. et al. Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA supply to T cells. J. Management. Launch 347, 521–532 (2022).
Bitounis, D., Jacquinet, E., Rogers, M. A. & Amiji, M. M. Methods to cut back the dangers of mRNA drug and vaccine toxicity. Nat. Rev. Drug Discov. 23, 281–300 (2024).
Kon, E., Advert-El, N., Hazan-Halevy, I., Stotsky-Oterin, L. & Peer, D. Focusing on most cancers with mRNA-lipid nanoparticles: key concerns and future prospects. Nat. Rev. Clin. Oncol. 20, 739–754 (2023).
Kumari, A., Kaur, A. & Aggarwal, G. The rising potential of siRNA nanotherapeutics in remedy of arthritis. Asian J. Pharm. Sci. 18, 100845 (2023).
Li, Z. et al. Synergistic twin cell remedy for atherosclerosis regression: ROS-responsive bio-liposomes co-loaded with geniposide and emodin. J. Nanobiotechnol. 22, 129 (2024).
Nasra, S., Bhatia, D. & Kumar, A. Focused macrophage re-programming: synergistic remedy with methotrexate and RELA siRNA folate-liposome in RAW264.7 cells and arthritic rats. Adv. Well being. Mater. 13, e2400679 (2024).
Ma, J., Ding, L., Peng, X., Jiang, L. & Liu, G. Latest advances of engineered cell membrane-based nanotherapeutics to fight inflammatory illnesses. Small 20, e2308646 (2024).
Dai, Q. et al. Quantifying the ligand-coated nanoparticle supply to most cancers cells in stable tumors. ACS Nano 12, 8423–8435 (2018).
Yan, H. et al. Engineering cell membrane-based nanotherapeutics to focus on irritation. Adv. Sci. 6, 1900605 (2019).
Melendez, E. et al. Pure killer cells act as an extrinsic barrier for in vivo reprogramming. Growth 149, dev200361 (2022).
Wu, J. et al. Macrophage phenotypic swap orchestrates the irritation and restore/regeneration following acute pancreatitis damage. eBioMedicine 58, 102920 (2020).
Manohar, M. et al. Novel circulating and tissue monocytes in addition to macrophages in pancreatitis and restoration. Gastroenterology 161, 2014–2029 (2021).
Wu, L. et al. Annexin A1 alleviates kidney damage by selling the decision of irritation in diabetic nephropathy. Kidney Int. 100, 107–121 (2021).
Liu, X. et al. USP25 deficiency exacerbates acute pancreatitis through up-regulating TBK1-NF-κB signaling in macrophages. Cell Mol. Gastroenterol. Hepatol. 14, 1103–1122 (2022).
Wan, J. C. M. et al. Liquid biopsies come of age: in the direction of implementation of circulating tumour DNA. Nat. Rev. Most cancers 17, 223–238 (2017).
Maltbaek, J. H., Cambier, S., Snyder, J. M. & Stetson, D. B. ABCC1 transporter exports the immunostimulatory cyclic dinucleotide cGAMP. Immunity 55, 1799–1812 (2022).
Zhou, Y. et al. Blockade of the phagocytic receptor MerTK on tumor-associated macrophages enhances P2X7R-dependent STING activation by tumor-derived cGAMP. Immunity 52, 357–373.e9 (2020).
Lee, G. Y. et al. Hyaluronic acid nanoparticles for lively focusing on atherosclerosis. Biomaterials 53, 341–348 (2015).
Gao, C. et al. Remedy of atherosclerosis by macrophage-biomimetic nanoparticles through focused pharmacotherapy and sequestration of proinflammatory cytokines. Nat. Commun. 11, 2622 (2020).
Zhou, M. et al. Focused supply of hyaluronic acid-coated stable lipid nanoparticles for rheumatoid arthritis remedy. Drug Deliv. 25, 716–722 (2018).
Sousa de Almeida, M. et al. Understanding nanoparticle endocytosis to enhance focusing on methods in nanomedicine. Chem. Soc. Rev. 50, 5397–5434 (2021).
Pan, Y. et al. Synergistic inhibition of pancreatic most cancers with anti-PD-L1 and c-Myc inhibitor JQ1. Oncoimmunology 8, e1581529 (2019).
Pan, Y. et al. Growth of a novel mannequin of hypertriglyceridemic acute pancreatitis in mice. Sci. Rep. 7, 40799 (2017).
Sendler, M. et al. Cathepsin B-mediated activation of trypsinogen in endocytosing macrophages will increase severity of pancreatitis in mice. Gastroenterology 154, 704–718.e10 (2018).
Deng, L. et al. STING-dependent cytosolic DNA sensing promotes radiation-induced sort I interferon-dependent antitumor immunity in immunogenic tumors. Immunity 41, 843–852 (2014).
Ahn, J., Xia, T., Rabasa Capote, A., Betancourt, D. & Barber, G. N. Extrinsic phagocyte-dependent STING signaling dictates the immunogenicity of dying cells. Most cancers Cell 33, 862–873.e5 (2018).
Ablasser, A. et al. Cell intrinsic immunity spreads to bystander cells through the intercellular switch of cGAMP. Nature 503, 530–534 (2013).
Luteijn, R. D. et al. SLC19A1 transports immunoreactive cyclic dinucleotides. Nature 573, 434–438 (2019).
Zhou, C. et al. Switch of cGAMP into bystander cells through LRRC8 volume-regulated anion channels augments STING-mediated interferon responses and anti-viral immunity. Immunity 52, 767–781.e6 (2020).
Kosicka, A. et al. Attenuation of plasma annexin A1 in human weight problems. FASEB J. 27, 368–378 (2013).
De Ponti, F. F. & Scott, C. L. Modulating hepatic macrophages with annexin A1 in non-alcoholic steatohepatitis. Clin. Sci. 136, 1111–1115 (2022).
Locatelli, I. et al. Endogenous annexin A1 is a novel protecting determinant in nonalcoholic steatohepatitis in mice. Hepatology 60, 531–544 (2014).
Morioka, S. et al. Efferocytosis induces a novel SLC program to advertise glucose uptake and lactate launch. Nature 563, 714–718 (2018).
Pan, Y. et al. Single-cell RNA sequencing reveals compartmental transforming of tumor-infiltrating immune cells induced by anti-CD47 focusing on in pancreatic most cancers. J. Hematol. Oncol. 12, 124 (2019).
Chondronasiou, D. et al. Deciphering the roadmap of in vivo reprogramming towards pluripotency. Stem Cell Rep. 17, 2501–2517 (2022).
He, R. et al. SULF2 enhances GDF15-SMAD axis to facilitate the initiation and development of pancreatic most cancers. Most cancers Lett. 538, 215693 (2022).
Li, L. et al. Integrative proteogenomic characterization of early esophageal most cancers. Nat. Commun. 14, 1666 (2023).
Hamilton, A. G. et al. Ionizable lipid nanoparticles with built-in immune checkpoint inhibition for mRNA CAR T cell engineering. Adv. Well being. Mater. 12, e2301515 (2023).
Flores, A. M. et al. Professional-efferocytic nanoparticles are particularly taken up by lesional macrophages and forestall atherosclerosis. Nat. Nanotechnol. 15, 154–161 (2020).
